The pharmaceutical industry is aggressively evolving, with substantial demand for high-efficacy Active Pharmaceutical Ingredients (APIs). Dulaglutide, a diabetes drug, is a key example of this trend. To address this demand, US-based manufacturing services are gaining traction. These providers offer a comprehensive suite of solutions, from research